Complexation of insecticide chlorantraniliprole with human serum albumin: Biophysical aspects

Chlorantraniliprole is a novel insecticide belonging to the diamide class of selective ryanodine receptor agonists. A biophysical study on the binding interaction of a novel diamide insecticide, chlorantraniliprole, with staple in vivo transporter, human serum albumin (HSA) has been investigated utilizing a combination of steady-state and time-resolved fluorescence, circular dichroism (CD), and molecular modeling methods. The interaction of chlorantraniliprole with HSA gives rise to fluorescence quenching through static mechanism, this corroborates the fluorescence lifetime outcomes that the ground state complex formation and the predominant forces in the HSA-chlorantraniliprole conjugate are van der Waals forces and hydrogen bonds, as derived from thermodynamic analysis. The definite binding site of chlorantraniliprole in HSA has been identified from the denaturation of protein, competitive ligand binding, and molecular modeling, subdomain IIIA (Sudlow's site II) was designated to possess high-affinity binding site for chlorantraniliprole. Moreover, using synchronous fluorescence, CD, and three-dimensional fluorescence we testified some degree of HSA structure unfolding upon chlorantraniliprole binding.     

Combined molecular docking and multi-spectroscopic investigation on the interaction between Eosin B and human serum albumin

The binding of Eosin B to human serum albumin (HSA) was studied using molecular docking, fluorescence, UV–vis, circular dichroism (CD) and Fourier transform infrared (FT-IR) spectroscopy. The mechanism of interaction between Eosin B and HSA in terms of the binding parameters, the thermodynamic functions and the effect of Eosin B on the conformation of HSA were investigated. Protein-ligand docking study indicated that Eosin B bound to residues located in the subdomain IIA of HSA and Eosin B–HSA complex was stabilized by hydrophobic force and hydrogen bonding. In addition, fluorescence data revealed that Eosin B strongly quenched the intrinsic fluorescence of HSA through a static quenching procedure. Furthermore, alteration of the secondary structure of HSA in the presence of the dye was conformed by UV–vis, FT-IR and CD spectroscopy.     

Transport of a Cancer Chemopreventive Polyphenol,Resveratrol: Interaction with Serum Albumin and Hemoglobin

Resveratrol is a natural phytoalexin with pharmacologic effects on several human diseases: carcinogenesis, coronary heart disease and neurodegenerative disease. Due to its poor water solubility, resveratrol must be bound to proteins to keep it at a high concentration in serum. In our work, the bindings of resveratrol to plasma proteins, human serum albumin (HSA) and hemoglobin (Hb), have been investigated systematically by fluorescence quenching technique, synchronous fluorescence, UV–vis absorption spectroscopy, circular dichroism (CD) spectroscopy and molecular modeling method. The fluorescence data show that the binding of resveratrol to HSA or Hb is a static quenching procedure and each protein has only one binding site for the drug. The binding constant of resveratrol to HSA is larger than that of resveratrol to Hb at corresponding temperature, which indicates that the affinity of HSA toward the drug is higher than that of Hb. The CD spectroscopy indicates that the secondary structures of the proteins are changed in the presence of resveratrol with the reduction of α-helices, which decreased about 18.75% for HSA and 9.43% for Hb at the drug to proteins molar ratio of 2. Thermodynamic analysis and molecular modeling suggest that hydrophobic interaction plays a major role in the binding of resveratrol to HSA, and hydrogen bonding is the mainly binding force in the binding of resveratrol to Hb. The study of molecular modeling shows that resveratrol is located in the hydrophobic cavity between subdomain IB and IIA of HSA (the entrance of site I), or located in the central cavity of Hb (partial to the subunit A).     

Structural analysis and binding domain of albumin complexes with natural dietary supplement humic acid

Humic acid, a natural ionic molecule, is rapidly being recognized as one of the crucial elements in our modern diets of the new century. A biophysical protocol utilizing circular dichroism (CD), steady state and time-resolved fluorescence for the investigation of the complexation of the humic acid to the staple in vivo transporter, human serum albumin (HSA), as a model for protein-humic substances, is proclaimed. The alterations of CD and three-dimensional fluorescence suggest that the polypeptide chain of HSA partially folded after complexation with humic acid. The data of fluorescence emission displayed that the binding of humic acid to HSA is the formation of HSA-humic acid complex with an association constant of 10⁴ M⁻¹; this corroborates the fluorescence lifetime measurements that the static mechanism was operated. The precise binding domain of humic acid in HSA has been verified from the denaturation of albumin, hydrophobic ANS displacement, and site-specific ligands; subdomain IIA (Sudlow's site I) was earmarked to possess high-affinity for humic acid. The observations are relevant for other albumin-humic substance systems when the ligands have analogous configuration with humic acid.     

Complexes between C.I. Acid Orange 6 and human serum albumin, a multi-spectroscopic approach to investigate the binding behavior

The interaction mechanism of Acid Orange 6 (AO6) with human serum albumin (HSA) was investigated firstly by using fluorescence quenching technique, UV absorbance, circular dichroism (CD), Fourier transform infrared (FT-IR), three-dimensional fluorescence spectroscopy in combination with molecular modeling method under simulative physiological conditions. Fluorescence data indicated that there is a single class of binding sites between AO6 and HSA, and the alterations of HSA secondary structure in the presence of AO6 was confirmed by synchronous fluorescence, UV, CD, FT-IR and three-dimensional fluorescence spectra. The efficiency of fluorescence resonance energy transfer provided the binding distance (r) of 2.83 nm for AO6-HSA system. Furthermore, the thermodynamic parameters enthalpy change (ΔH⁰) and entropy change (ΔS⁰) for the reaction were calculated to be −5.77 kJ mol⁻¹ and 109.42 J mol⁻¹ K⁻¹, respectively, according to Van't Hoff equation, these data suggested that both hydrophobic forces and hydrogen bonding play a major role in the binding of AO6 to HSA, which agrees well with the results of molecular modeling study. Experimental results showed that the interaction between AO6 and HSA induced a conformational change of HSA, which was proved by the qualitative and quantitative analysis data of different spectroscopic techniques under simulative physiological conditions.     

Study on the interaction between tabersonine and human serum albumin by optical spectroscopy and molecular modeling methods

The mechanism of interaction between tabersonine (TAB) and human serum albumin (HSA) was investigated by the methods of fluorescence spectroscopy, UV–vis absorption spectroscopy and molecular modeling under simulative physiological conditions. Results obtained from analysis of fluorescence spectrum and fluorescence intensity indicated that TAB has a strong ability to quench the intrinsic fluorescence of HSA through a static quenching procedure. The binding site number n and apparent binding constant K_a, corresponding thermodynamic parameters ΔG, ΔH and ΔS at different temperatures were calculated. The distance r between donor (human serum albumin) and acceptor (tabersonine) was obtained according to the Förster theory of non-radiation energy transfer. The effect of common ions on binding constant was also investigated. The synchronous fluorescence and three-dimensional fluorescence spectra were used to investigate the structural change of HSA molecules with addition of TAB. Furthermore, the study of molecular modeling indicated that TAB could bind to the site I of HSA and hydrophobic interaction was the major acting force, which was in agreement with the binding mode study.     

Specificity and affinity of phenosafranine protein adduct: Insights from biophysical aspects

Phenosafranine is a toxic and recalcitrant compound, whose capacity to intercalate with double stranded DNA has been shown. In this contribution, a biophysical discuss on the conjugation of phenosafranine with two model proteins human serum albumin (HSA) and lysozyme (Lys) has been identified utilizing a combination of molecular modeling, steady state and time-resolved fluorescence and circular dichroism (CD) approaches. The accurate binding domain of phenosafranine in protein has been characterized from molecular modeling, subdomain IIIA of HSA and Trp-62, Trp-63 and Trp-108 residues of Lys was designated to possess high-affinity for this compound, the dominant forces in the protein–phenosafranine adduct are hydrogen bonds and π–π interactions, but hydrophobic interactions between dye and Lys are also not exclude. The data of fluorescence displayed that the complex of phenosafranine with protein produces quenching through static property, this corroborates the time-resolved fluorescence results that the ground state complex formation with a moderate affinity of 10⁴ M^?1. Moreover, via synchronous fluorescence, CD and three-dimensional fluorescence we indicated some extent of polypeptide chain of protein partially unfolding upon conjugation with phenosafranine. Through this work, we anticipate it can supply salient clues on the toxicological action of phenosafranine and other azines, which have analogous configuration with phenosafranine.     

Characterization of Interaction Between Bergenin and Human Serum Albumin in Membrane Mimetic Environments

The interaction between bergenin and human serum albumin (HSA) in AOT/isooctane/water microemulsions was studied by fluorescence quenching technique in combination with UV absorption spectroscopy, circular dichroism (CD) spectroscopy and dynamic light scattering (DLS) technique. Fluorescence data in omega (o) 20 microemulsions revealed the presence of a binding site of bergenin on HSA and its binding constants (K) were 1.64 x 10(4), 1.44 x 10(4), 1.26 x 10(4) and 1.09 x 10(4) M(-1) at 289, 296, 303, and 310 K, respectively. The binding of bergenin with HSA in microemulsions was stronger than that in buffer solution. The alterations of protein secondary structure in the microemulsions in the absence and presence of bergenin compared with the free form of HSA in buffer were qualitatively and quantitatively analyzed by the evidence from CD spectra. Enthalpy and entropy changes for the reaction were calculated to be -14.45 kJ mol(-1) and 30.76 J mol(-1) K(-1). These results indicated that bergenin bound to HSA mainly by a hydrophobic interaction in microemulsions which was in agreement with the result of the molecular modeling study. The DLS data suggested that HSA may locate at the interface of the microemulsion and bergenin could interact with them.     

Spectrophotometric studies on the interaction between pazufloxacin mesilate and human serum albumin or lysozyme

The binding of pazufloxacin mesilate (PZFX) to human serum albumin (HSA) or lysozyme (Lys) was investigated using spectrophotometric techniques. The intrinsic fluorescence of both HSA and Lys was strongly quenched by PZFX. This effect was rationalized in terms of a static quenching procedure. Negative values of ΔH⁰ and ΔS⁰ for the formation of PZFX-HSA or PZFX-Lys complex implied that both hydrogen bonds and hydrophobic interactions might play a significant role in PZFX binding to HSA or Lys. The binding distances deduced from the efficiency of energy transfer were 4.04 and 3.21 nm for PZFX-HSA and PZFX-Lys systems, respectively. Furthermore, association constants and binding mechanism were successfully derived from the synchronous fluorescence spectra. Circular dichroism (CD) spectra and UV/vis detections supported a change in the secondary structure of proteins caused by the interaction of PZFX with HSA or Lys.     

Interaction of 1-cyanoethyl-5-chlorouracil with human and bovine serum albumins

The interactions of human (HSA) and bovine (BSA) serum albumins with 1-cyanoethyl-5-chlorouracil (CECU) were investigated by fluorescence spectroscopy, UV absorption spectroscopy, and molecular modeling methods under the simulated physiological conditions. The results of fluorescence measurements indicate that CECU has a strong ability to quench the intrinsic fluorescence of both HSA and BSA through a static quenching procedure. The binding constants (K) at different temperatures and thermodynamic parameters, enthalpy change (ΔH), and entropy change (ΔS) were calculated according to fluorescence data. The results show that hydrophobic interaction is a predominant intermolecular force for stabilizing the complex, which is in agreement with the results of molecular modeling study. The effect of some normal ions on the binding constants is also discussed. Published in Zhurnal Prikladnoi Spektroskopii, Vol. 75, No. 5, pp. 737–745, September–October, 2008.     

Interaction of fisetin with human serum albumin by fluorescence, circular dichroism spectroscopy and DFT calculations: binding parameters and conformational changes

The interaction between fisetin, an antioxidant and neuroprotective flavonoid, and human serum albumin (HSA) is investigated by means of fluorescence (steady-state, synchronous, time-resolved) and circular dichroism (CD) spectroscopy. The formation of a 1:1 complex with a constant of about 10⁵ M⁻¹ was evidenced. Förster's resonance energy transfer and competitive binding with site markers warfarin and ibuprofen were considered and discussed. Changes in the CD band of HSA indicate a decrease in the α-helix content upon binding. An induced CD signal for bound fisetin was observed and rationalized in terms of density functional theory calculations.     

Studies on the interaction between scopoletin and two serum albumins by spectroscopic methods

The interactions of scopoletin to bovine serum albumin (BSA) and human serum albumin (HSA) have been investigated by spectroscopic methods. The fluorescence tests indicated that the formation mechanism of scopoletin–BSA/HSA complexes belonged to the static quenching. The displacement experiments suggested that scopoletin primarily bound to tryptophan residues of BSA/HSA within site I (subdomain IIA). The binding distance of scopoletin to BSA/HSA was 2.38/2.34 nm. The thermodynamic parameters (ΔG, ΔH and ΔS) calculated on the basis of different temperatures revealed that the binding of BSA–scopoletin was mainly depended on van der Waals interaction and hydrogen bond, and yet the binding of HSA–scopoletin was strongly relied on the hydrophobic interaction and electrostatic interaction. The results of synchronous fluorescence, 3D fluorescence, UV–vis absorption, and FT-IR spectra showed that the conformations of BSA and HSA altered with the addition of scopoletin. In addition, the effects of some common ions on the binding constants of scopoletin to proteins were also investigated.     

Fluorescence spectrometric studies on the binding of puerarin to human serum albumin using warfarin, ibuprofen and digitoxin as site markers with the aid of chemometrics

The interaction of puerarin with human serum albumin (HSA) in pH 7.4 Tris-HCl buffer has been investigated by fluorescence, Fourier transform infrared (FT-IR) and circular dichroism (CD) spectroscopy. The results revealed the presence of static type of quenching mechanism in the binding of puerarin to HSA. The association constants (K_a) between puerarin and HSA were obtained according to Modified Stern-Volmer equation. The calculated thermodynamic parameters indicated that the binding of puerarin to HSA was driven mainly by hydrophobic interaction. The competitive experiments of site markers suggested that the binding site of puerarin to HSA was located in the region of subdomain IIA (sudlow site I). Further, a chemometrics approach, parallel factor analysis (PARAFAC), was applied to resolve the measured three-way synchronous fluorescence spectra data of the competitive interaction between puerarin and warfarin with HSA. The concentration information for the three reaction components, warfarin, puerarin and puerarin−HSA, in the system at equilibrium was obtained simultaneously. The PARAFAC analysis indicated that puerarin in the puerarin-HSA complex was displaced by warfarin, which confirmed the binding site of puerarin to HSA was located in site I. Moreover, the results of CD and FT-IR spectra demonstrated that the secondary structure of HSA was changed in the presence of puerarin.     

The binding of 3-(p-bromophenyl)-5-methyl-thiohydantoin with human serum albumin: Investigation by fluorescence spectroscopy and molecular model

The binding of 3-(p-bromophenyl)-5-methyl-thiohydantoin (BPMT) with human serum albumin (HSA) was investigated by fluorescence spectroscopy in combination with UV absorption spectrum under physiological conditions. The intrinsic fluorescence of HSA was quenched by BPMT through static quenching mechanism and the fluorescence emission spectrum of HSA exhibited appreciable hypsochromic shift with increasing concentration of BPMT. The binding constants (K) of HSA with BPMT and the number binding sites (n) at different temperatures, thermodynamic parameter enthalpy changes (ΔH) and entropy changes (ΔS) of HSA-BPMT have been calculated according to the relevant fluorescence data, indicating that the hydrophobic interaction played a major role, which was consistent with the result of molecular modeling study.     

Multiple Spectroscopic,Docking and Cytotoxic Study of a Synthesized 2,2′ Bipyridin Phenyl Isopentylglycin Pt(II) Nitrate Complex: Human Serum Albumin and Breast Cancer Cell Line of MDA-MB231 as Targets

In the present study, the biological activities of a new synthesized Pt(II)-complex, 2,2′ bipyridinphenyl isopentylglycin Pt(II) nitrate was investigated via its interaction with the most important blood carrier protein of human serum albumin (HSA), using fluorescence and Far-UV circular dichroism (CD) spectroscopic techniques and also molecular docking. Moreover, cytotoxicity activity of the complex was studied against breast cancer cell line of MDA MB231 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The Pt(II)-complex has a strong ability to quench the intrinsic fluorescence of HSA through a static quenching mechanism. According fluorescence quenching data, the binding parameters of the interaction were calculated and showed that hydrophobic interaction has an important role. The molecular docking results in coherent with fluorescence measurements illustrated that Pt(II) complex can bind to HSA at one position that located in the hydrophobic cavity of groove between drug site I and II. Also, experimental data on driving force in binding site was confirmed whereas theoretical results demonstrated Pt(II) complexinteract to HSA by hydrophobic interaction. Far-UV-CD results showed that Pt(II)-complex induced an increasing in the content of α-helical structure of the protein and stabilized it. Also, MTT assay represented growth inhibitory effect of the complex toward the breast cancer cell line.     

新型羧酸卟啉锌(Ⅱ)配合物与人血清蛋白的作用

卟啉是一种潜在有效的光动力治疗癌症的光敏剂,部分已用于临床实验中。人血清蛋白(HSA)是药物的运输载体,详细研究两者的相互作用对于阐述卟啉类药物的药代动力学行为具有重要的意义。合成了一种新型水溶性羧酸锌(Ⅱ)卟啉配合物(2-Zn),并通过紫外可见吸收光谱、荧光光谱、圆二色(CD)光谱和分子对接模拟研究了其与人血清蛋白(HSA)的相互作用。结果表明：2-Zn以静态猝灭的方式猝灭了HSA的内源荧光,通过计算得到其与HSA在298和310 K下相互作用的猝灭常数分别为1.96×104和1.37×104 L·mol-1、结合常数分别为1.93×104和1.50×104 L·mol-1、结合位点数均为1,两者间的结合作用力以静电作用为主,同时也存在氢键和疏水作用。位点竞争实验表明2-Zn主要结合在位点Ⅱ处;根据Forster非辐射能量理论得到两者的结合距离和能量转移效率分别为4.01 nm和0.163。紫外吸收光谱,同步荧光和CD光谱显示2-Zn与HSA的相互作用影响了HSA 的构象,表现为α-螺旋的含量降低;分子对接模拟结果表明2-Zn通过疏水、静电和氢键作用嵌入HSA分子的亚结构域IIIA(site Ⅱ)的疏水腔内,与位点竞争实验和热力学判据所得的结果相一致。     

光谱法和分子对接法研究和比较两种全氟羧酸与人血清白蛋白的结合模式

全氟羧酸(PFCAs)由于具有既亲水又疏水的表面活性剂特性,被广泛应用于工业和生活产品中。全氟十一酸(PFUnA)和全氟十三酸(PFTriA)是长链PFCAs类的典型代表,但近年来它们越来越频繁的在人体中检测到,并且发现表现出内分泌干扰效应、发育毒性和致畸性。本文以光谱学和分子对接为基础,探索PFUnA和PFTriA与人体最丰富的蛋白人血清白蛋白(HSA)的结合模式。结果表明,PFUnA和PFTriA均通过动静态猝灭过程猝灭HSA的内源荧光,与HSA只有一个强亲和位点,且PFUnA与HSA的结合比PFTriA更紧密。根据热力学计算结果,可知PFUnA与HSA结合的焓变、熵变分别为-26.32 kJ·mol-1和21.76 J·mol-1·K-1,其结合作用主要依靠静电引力,而PFTriA主要通过范德华力和卤键与HSA结合,是放热熵减过程,其焓变和熵变分别为-39.69 kJ·mol-1和-25.66 J·mol-1·K-1。计算得到的结合距离(r<8 nm)显示从HSA到PFUnA和PFTriA发生了非辐射能量转移。三维荧光光谱和圆二色谱表明,PFUnA和PFTriA与HSA的结合不仅可以改变HSA的构象和微环境,还可以引起α-螺旋稳定性降低。取代实验和分子对接进一步显示PFUnA 和PFTriA通过极性键、疏水作用力和卤键等与HSA的亚域ⅡA疏水腔有高亲和性,且荧光团Trp残基处于结合位置中,进一步证明PFUnA和PFTriA可以猝灭HSA的荧光。本文研究结果为阐明长链PFCAs在机体内与血清蛋白的结合机理提供了完整可靠的数据,并为长链PFCAs的毒性评价和毒理学研究提供了理论依据。     

光谱法联合分子对接和等温滴定微量热法研究全氟壬酸与人血清白蛋白的相互作用

全氟壬酸(PFNA)是在血清中检测到第三多的全氟烷酸类(PFAAs)新型有毒环境污染物。目前PFNA对人血清白蛋白(HSA)结构甚至是功能的影响还处于起步阶段,借助于多光谱、分子对接和等温滴定微量热(ITC)技术研究了PFNA和HSA相互作用的结合机理。所有荧光数据均进行了内滤光校正以获得更准确的结合参数。荧光结果表明PFNA通过动静态猝灭方式可以猝灭HSA的内源荧光。取代实验和分子对接结果表明,PFNA主要通过极性键、疏水力和卤素键键合在HSA亚域ⅡA疏水腔中,最佳对接自由能为-26.54 kJ·mol-1,表明PFNA分子与HSA有较大的结合亲和力。ITC表明两者的结合属于两类结合位点模型并给出了相应的热力学参数：第一类结合位点有较大的亲和力,属于焓驱动,静电力和卤键作为主要驱动力;第二类结合位点亲和力较小,主要驱动力是疏水力。三维荧光光谱揭示PFNA与HSA生成复合物后,可以改变HSA的构象,引起Trp和Tyr残基微环境疏水性增强。圆二色谱(CD)定量测定了HSA与PFNA作用前后的二级结构含量：α-螺旋、β-折叠和β-转角含量分别降低14.3%,5.3%和3.5%,无规卷曲含量从14.4%增加到37.5%。以上结果表明,PFNA与HSA的结合可以改变HSA的二级结构,进而可能影响HSA的生理功能。结果阐述了PFNA与HSA相互作用机理,并且为PFNA在体内的运输和分配提供了可靠的生物物理和生物化学的相关依据。     

利用光谱法和分子对接技术研究4-乙基-2-甲氧基苯酚与人血清白蛋白之间的相互作用

4-乙基-2-甲氧基苯酚是一种被广泛应用的食品添加剂,但它也具有一定的毒性,为了探究4-乙基-2-甲氧基苯酚对人体的影响,将多种光谱技术与分子模拟等技术结合起来对4-乙基-2-甲氧基苯酚与人血清白蛋白Human Serum Albumin(HSA)之间的相互作用进行了较全面的研究。紫外吸收光谱的结果说明,4-乙基-2-甲氧基苯酚与人血清白蛋白之间形成了新的复合物。荧光光谱的结果说明了4-乙基-2-甲氧基苯酚的存在,可以增加人血清白蛋白的荧光强度。通过15 nm的同步荧光光谱同时结合荧光增强效应方程可以计算出4-乙基-2-甲氧基苯酚与人血清白蛋白之间的结合常数,且它们之间的结合常数随着温度的升高而减小。热力学参数表明,4-乙基-2-甲氧基苯酚主要靠氢键和疏水作用力与人血清白蛋白结合在一起。同步荧光光谱、三维荧光光谱和圆二色光谱的结果说明人血清白蛋白的构象会随着4-乙基-2-甲氧基苯酚的作用而发生一定的变化。分子对接得到结果说明4-乙基-2-甲氧基苯酚键合在人血清白蛋白的IB区域。     

Spectroscopic and docking studies of the binding of two stereoisomeric antioxidant catechins to serum albumins

The interactions of two stereoisomeric antioxidant flavonoids, catechin (C) and epicatechin (EC) with bovine serum albumin (BSA) and human serum albumin (HSA), have been investigated by steady state and time resolved fluorescence, phosphorescence, circular dichroism (CD), FTIR and protein–ligand docking studies. The steady-state fluorescence studies indicate a single binding site for both the ligands. FTIR spectra suggest that in both the albumins, C and EC stabilize the α-helix at the cost of a corresponding loss in the β-sheet structure. CD studies have been carried out using (±)C, and both the epimers (+)C and (?)C. The low temperature phosphorescence and protein–ligand [(+), (?) and (±) forms of C and EC] docking studies indicate that the ligands bind in the proximity of Trp 134 of BSA and Trp 214 of HSA, thereby changing their solvent accessible surface areas (ASA). Asn 158 and Glu 130 side chains are found to be within the hydrogen bonding distance from the phenolic –OH groups of C and EC in the case of BSA complex. C and EC are located within the binding pocket of sub-domain IIa of HSA.